Health | infostain

363 results found

Ingrezza is the brand name for valbenazine, a prescription medicine classified as a vesicular monoamine transporter 2 inhibitor. It is approved for adults with tardive dyskinesia and for chorea . . .
Read More
Multiple sclerosis is a condition in which the immune system affects the central nervous system, including the brain and spinal cord. The condition can have different patterns and symptoms, . . .
Read More
Relapsing multiple sclerosis is a condition in which periods of new or worsening neurological symptoms can occur, followed by periods of partial or complete recovery. Long term management focuses . . .
Read More
Multiple sclerosis is a condition affecting the brain and spinal cord, and its symptoms can vary considerably between individuals. Rehabilitation is not limited to a particular stage of the . . .
Read More
Multiple sclerosis (MS) is a long term condition affecting the central nervous system, particularly the brain and spinal cord. The condition can affect people differently, and symptoms may appear, . . .
Read More
Multiple sclerosis is a chronic condition affecting the central nervous system, including the brain and spinal cord. Disease modifying therapies, commonly called DMTs, are designed to influence the underlying . . .
Read More
Relapsing multiple sclerosis is a form of multiple sclerosis in which periods of neurological symptoms, known as relapses, are followed by periods of recovery or remission. Treatment is generally . . .
Read More
Multiple sclerosis is a chronic condition affecting the central nervous system, and its course can vary considerably between individuals. In relapsing forms of MS, periods of new or worsening . . .
Read More
Relapsing multiple sclerosis can involve episodes of neurological symptoms known as relapses, followed by periods of recovery or stability. Management aims to reduce disease activity and its effects on . . .
Read More
Relapsing multiple sclerosis is a form of multiple sclerosis characterized by episodes of new or worsening neurological symptoms followed by periods of improvement or remission. Treatment and disease management . . .
Read More